Record: 41

08/07/2018

Company Report

Pages: 6

Early Look at Phase 3 Lead-In Points to Getting Cells to Patients Faster

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 42

08/01/2018

Company Report

Pages: 6

AGI-134 Hits the Clinic as Expected; Dual-Pronged Mechanism Should Yield Intriguing Results; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 43

07/30/2018

Daily Note

Pages: 3

Study Expanding to Explore Third ''Punch''; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Record: 44

06/18/2018

Daily Note

Pages: 6

New Biomarker Directly Correlates With BL-8040 AML Induced Survival; Plethora of Upcoming Catalysts; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 45

05/22/2018

Company Report

Pages: 6

1Q18 Results; Prepping for Multiple Data Catalysts

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 46

03/06/2018

Company Report

Pages: 6

2017 Results; Investors Should Be Prepped Ahead of Several 2H18 Data Catalysts; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 47

01/17/2018

Daily Note

Pages: 6

Looks Like ''8040 Is Opening the Door; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 48

12/21/2017

Company Report

Pages: 6

The GENESIS of Company''s First Pivotal Program; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 49

12/06/2017

Company Report

Pages: 12

Brewing Excitement for 2018; Investor Day Recap; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 50

12/04/2017

Daily Note

Pages: 5

AML Needle Continues to Point in Right Direction; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Record: 51

11/21/2017

Company Report

Pages: 5

3Q17 Results; Looking Toward a Busy Data Year in 2018; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Record: 52

10/18/2017

Daily Note

Pages: 5

Genentech Collaboration Continues to Expand as Expected; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Record: 53

09/26/2017

Company Report

Pages: 6

BL-8040 and Tecentriq Ready to BATTLE AML as Programs Expand

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Record: 54

08/09/2017

Company Report

Pages: 6

2Q17 Results; The Password Is: BL-8040; Reiterate Buy

Provider: Rodman & Renshaw, Co.

Price: 25.00

Record: 55

08/09/2017

Company Report

Pages: 6

2Q17 Results; The Password Is: BL-8040; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Price: 25.00

Record: 56

06/02/2017

Company Report

Pages: 5

Genentech Officially Presses Play; Meaningful Answers to Come; Reiterate Buy

Provider: Rodman & Renshaw, Co.

Price: 10.00

Record: 57

06/02/2017

Company Report

Pages: 5

Genentech Officially Presses Play; Meaningful Answers to Come; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Price: 10.00

Record: 58

05/26/2017

Company Report

Pages: 5

1Q17 Results; All Eyes on ''8040 Collaborations and Pivotal Plans

Provider: Rodman & Renshaw, Co.

Price: 10.00

Record: 59

05/26/2017

Company Report

Pages: 5

1Q17 Results; All Eyes on ''8040 Collaborations and Pivotal Plans

Provider: H.C. Wainwright & Co., Inc.

Price: 10.00

Record: 60

05/24/2017

Daily Note

Pages: 3

Corrected - Coverage Update - Healthcare

Provider: Roth Capital Partners, Inc.

Price: 10.00